T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial

~8 mi. (Auburn, Washington, +576 more cities)

MultiCare Auburn Medical Center

ERBB2 Amplification, +1 more biomarker

Breast Carcinoma

ado-trastuzumab emtansine, +1 more drug

targeted therapy

Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy

~8 mi. (Auburn, Washington, +744 more cities)

MultiCare Auburn Medical Center

Breast Carcinoma

axillary lymph node dissection, +1 more drug

radiation therapy, +1 more type

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

~8 mi. (Auburn, Washington, +825 more cities)

MultiCare Auburn Medical Center

AKT1 Mutation, +91 more biomarkers

Breast Carcinoma, +3 more conditions

adavosertib, +26 more drugs

immunotherapy, +1 more type

Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

~8 mi. (Auburn, Washington, +656 more cities)

MultiCare Auburn Medical Center

Deficient DNA Mismatch Repair (dMMR), +8 more biomarkers

Colon Adenocarcinoma, +1 more condition

atezolizumab, +3 more drugs

chemotherapy, +1 more type

S0820, Adenoma and Second Primary Prevention Trial

~8 mi. (Auburn, Washington, +616 more cities)

MultiCare Auburn Medical Center

Colon Carcinoma, +1 more condition

eflornithine, +2 more drugs

chemotherapy, +1 more type

Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer

~8 mi. (Auburn, Washington, +497 more cities)

MultiCare Auburn Medical Center

HER2 Positive

Breast Adenocarcinoma

atezolizumab, +4 more drugs

chemotherapy, +2 more types

Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

~8 mi. (Auburn, Washington, +100 more cities)

MultiCare Regional Cancer Center - Auburn

Fallopian Tube Adenocarcinoma, +14 more conditions

carboplatin, +2 more drugs

chemotherapy, +1 more type

A Phase 3 Efficacy, Safety and Tolerability Study of Zolbetuximab (Experimental Drug) Plus mFOLFOX6 Chemotherapy Compared to Placebo Plus mFOLFOX6 as Treatment for Gastric and Gastroesophageal Junction (GEJ) Cancer

~8 mi. (Auburn, Washington, +202 more cities)

MultiCare Regional Cancer Center - Gig Harbor

CLDN18 Expression, +1 more biomarker

Adenocarcinoma of the Gastroesophageal Junction, +1 more condition

modified FOLFOX6 regimen, +1 more drug

chemotherapy, +1 more type

Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

~8 mi. (Auburn, Washington, +822 more cities)

MultiCare Auburn Medical Center

ER Negative, +2 more biomarkers

Invasive Breast Carcinoma

carboplatin, +3 more drugs

chemotherapy

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

~8 mi. (Auburn, Washington, +954 more cities)

MultiCare Auburn Medical Center

Non-Small Cell Lung Carcinoma

crizotinib, +4 more drugs

chemotherapy, +2 more types

A Randomized Study of Olaparib or Placebo in Patients With Surgically Removed Pancreatic Cancer Who Have a BRCA1, BRCA2 or PALB2 Mutation, The APOLLO Trial

~8 mi. (Auburn, Washington, +201 more cities)

MultiCare Auburn Medical Center

BRCA1 Loss, +5 more biomarkers

Pancreatic Carcinoma

olaparib

targeted therapy

Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery

~8 mi. (Auburn, Washington, +387 more cities)

MultiCare Auburn Medical Center

ERBB2 Amplification

Breast Carcinoma

radiation therapy

radiation therapy